Scarica l'app Stockscreener
29.62
3.04%
-0.93
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CSTL Giù?
Forum
Previsione
Precedente Chiudi:
$30.55
Aprire:
$30.93
Volume 24 ore:
264.21K
Relative Volume:
0.65
Capitalizzazione di mercato:
$904.88M
Reddito:
$339.92M
Utile/perdita netta:
$-12.83M
Rapporto P/E:
-68.96
EPS:
-0.4295
Flusso di cassa netto:
$4.52M
1 W Prestazione:
-7.52%
1M Prestazione:
+28.11%
6M Prestazione:
-10.65%
1 anno Prestazione:
+49.45%
Intervallo 1D:
$29.58
$31.11
Intervallo di 1 settimana:
$29.58
$33.06
Portata 52W:
$17.72
$44.28
Castle Biosciences Inc Stock (CSTL) Company Profile
Nome
Castle Biosciences Inc
Settore
Industria
Telefono
866-788-9007
Indirizzo
1500 W. PARKWOOD AVE., FRIENDSWOOD, TX
Compare CSTL vs TMO, DHR, NTRA, IDXX, A
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CSTL
Castle Biosciences Inc
|
29.62 | 960.17M | 339.92M | -12.83M | 4.52M | -0.4295 |
TMO
Thermo Fisher Scientific Inc
|
588.29 | 222.96B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
202.45 | 144.67B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
309.93 | 45.54B | 2.50B | -226.32M | 71.51M | -1.6412 |
IDXX
Idexx Laboratories Inc
|
550.96 | 44.95B | 4.45B | 1.10B | 1.06B | 13.59 |
A
Agilent Technologies Inc
|
148.53 | 41.87B | 7.23B | 1.41B | 1.09B | 4.979 |
Castle Biosciences Inc Stock (CSTL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-12-14 | Iniziato | Guggenheim | Buy |
| 2023-01-05 | Iniziato | Scotiabank | Sector Outperform |
| 2022-01-07 | Iniziato | Stephens | Overweight |
| 2021-04-30 | Iniziato | Lake Street | Buy |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2019-12-27 | Reiterato | Canaccord Genuity | Buy |
| 2019-08-19 | Iniziato | BTIG Research | Buy |
| 2019-08-19 | Iniziato | Canaccord Genuity | Buy |
| 2019-08-19 | Iniziato | Robert W. Baird | Outperform |
| 2019-08-19 | Iniziato | SVB Leerink | Outperform |
Mostra tutto
Castle Biosciences Inc Borsa (CSTL) Ultime notizie
Quantinno Capital Management LP Purchases 36,144 Shares of Castle Biosciences, Inc. $CSTL - MarketBeat
Is Castle Biosciences Inc (CSTL) a Bargain After 3.0% Drop? GF V - GuruFocus
CSTL (CSTL) files notice to sell 24,908 common shares on NASDAQ - Stock Titan
CSTL (CSTL) insider and family trusts detail planned and recent stock sales - Stock Titan
Wasatch Advisors LP Sells 175,687 Shares of Castle Biosciences, Inc. $CSTL - MarketBeat
Castle Biosciences Raises Outlook as Melanoma, TissueCypher Tests Gain Traction - MarketBeat
Castle Biosciences at canaccord growth conference: growth broadens - Investing.com
Castle Biosciences, Inc. (CSTL) Stock Analysis: Exploring a 44% Upside Potential in the Diagnostics Sector - DirectorsTalk Interviews
Castle Biosciences (NASDAQ:CSTL) Insider Derek Maetzold Sells 20,356 Shares of Stock - MarketBeat
Tobin Juvenal Sells 1,301 Shares of Castle Biosciences (NASDAQ:CSTL) Stock - MarketBeat
Castle Biosciences (NASDAQ:CSTL) COO Sells 8,586 Shares of Stock - MarketBeat
Dimensional Fund Advisors LP Sells 104,038 Shares of Castle Biosciences, Inc. $CSTL - MarketBeat
Castle Biosciences (CSTL) Chief Commercial Officer Tobin Juvenal Sells 19,040 Shares - GuruFocus
Castle Biosciences (NASDAQ:CSTL) Insider Sells 1,730 Shares - MarketBeat
Insider Selling: Castle Biosciences (NASDAQ:CSTL) Insider Sells $323,652.40 in Stock - MarketBeat
Castle Biosciences (NASDAQ:CSTL) Insider Derek Maetzold Sells 6,480 Shares - MarketBeat
Insider Selling: Castle Biosciences (NASDAQ:CSTL) Insider Sells 17,310 Shares of Stock - MarketBeat
BTIG raises Castle Biosciences stock price target on strong revenue - Investing.com
BTIG Research Forecasts Strong Price Appreciation for Castle Biosciences (NASDAQ:CSTL) Stock - MarketBeat
CFO Awards honoree Frank Stokes of Castle Biosciences Inc. - The Business Journals
Renaissance Technologies LLC Has $13.08 Million Stock Holdings in Castle Biosciences, Inc. $CSTL - MarketBeat
Castle Biosciences (NASDAQ:CSTL) Raised to "Hold" at Wall Street Zen - MarketBeat
Form 144 Castle Biosciences For: 1 August By Investing.com - Investing.com Nigeria
Castle Biosciences, Inc. Stock 12‑Month Price Target Raised to $43.56, Implies 63% Upside - TradingView
Castle Biosciences Stock Price Forecast. Should You Buy CSTL? - StockInvest.us
CSTL (CSTL) insider schedules potential $630,000 sale of 22,500 shares - Stock Titan
Castle Biosciences, Inc. (CSTL) Stock Analysis: Unpacking a 59.68% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
Castle Biosciences Inc (CSTL) Institutional Confidence - TradingKey
Earnings Flash (CSTL) Castle Biosciences Posts Q2 Revenue of $103.5 Million, vs. FactSet Est of $86.2 Million - marketscreener.com
Earnings call transcript: Castle Biosciences tops Q2 2026 estimates, shares jump - Investing.com
Is Castle Biosciences (CSTL) Undervalued After Q2 Earnings Miss? GF Score: 81/100, Revenue at $103.5 Million - GuruFocus
Q2 2026 Castle Biosciences Inc Earnings Call Transcript - GuruFocus
Castle Biosciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Castle Biosciences Reports Second Quarter 2026 Results - PR Newswire
Castle Biosciences Raises FY26 Sales Guidance to $365-$375 Million - scanx.trade
Castle Biosciences CEO Maetzold sells $237,682 in company stock By Investing.com - Investing.com South Africa
Form 4 Castle Biosciences Inc For: 29 July By Investing.com - Investing.com Canada
Castle Biosciences CEO Maetzold sells $237,682 in company stock - Investing.com
Castle Biosciences, Inc. (NASDAQ:CSTL) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Castle Biosciences Inc (CSTL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Castle Biosciences Inc (CSTL) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Castle Biosciences Inc (CSTL) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Castle Biosciences Inc (CSTL) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Castle Biosciences Inc (CSTL) Cash Flow - TradingKey
Earnings Preview: CSTL to Report Financial Results Post-market on July 30 - Moomoo
Castle Biosciences Inc (CSTL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Castle Biosciences, Inc. (CSTL) Investor Outlook: Exploring A 67.89% Potential Upside - DirectorsTalk Interviews
CSTL|Castle Biosciences Inc|Price:25.093|Chg%:-0.387 - TradingKey
Castle Biosciences sets live webcast for Aug. 12 conference - Stock Titan
New York State Department of Health Approves Castle’s AdvanceAD-Tx Test - The Dermatology Digest
The Technical Signals Behind (CSTL) That Institutions Follow - Stock Traders Daily
Castle Biosciences Inc Azioni (CSTL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.69%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):